Cellect Biotechnology Ltd (APOP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cellect Biotechnology Ltd (APOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8153
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12
Accellta Enters into Agreement with Cellect Biomed 13
Equity Offering 14
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cellect Biotech Raises Funds through Private Placement of Shares 20
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22
Cellect Biotechnology Ltd – Key Competitors 23
Cellect Biotechnology Ltd – Key Employees 24
Cellect Biotechnology Ltd – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
May 17, 2018: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2018 Financial Results 26
Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 22, 2017: Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2017 Financial Results 29
Aug 21, 2017: Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2017 Financial Results 30
May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 31
Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 32
Corporate Communications 34
May 10, 2018: Former GE Healthcare Executive to Join Cellect as Chief Business Officer 34
Oct 19, 2017: Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer 35
Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 36
May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect’s Advisory Board 37
Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors 38
Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board 39
Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 40
Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 41
Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 42
Product News 43
03/27/2017: Cellect Announces Successful First Cancer Patient Stem Cell Transplant 43
02/21/2017: Cellect Announces Positive Clinical Trial Results 44
02/08/2017: First Cancer Patient Treated In Phase I/II Trial of ApoGraft 45
Product Approvals 46
Sep 05, 2017: FDA Grants Orphan Drug Status to Cellect’s ApoGraft for Acute GvHD and Chronic GvHD 46
May 03, 2017: Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S. 47
Other Significant Developments 48
Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12
Accellta Enters into Agreement with Cellect Biomed 13
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cellect Biotech Raises Funds through Private Placement of Shares 20
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22
Cellect Biotechnology Ltd, Key Competitors 23
Cellect Biotechnology Ltd, Key Employees 24

List of Figures
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Cellect Biotechnology Ltd (APOP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lexmark International Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lexmark International Inc (Lexmark) a subsidiary of Ninestar Corp., provider of imaging and printing solutions. It manufactures, develops and supplies printing and imaging solutions, managed print services, device management, document workflow, business process and content management solutio …
  • El Pollo Loco Holdings, Inc.:企業の戦略・SWOT・財務情報
    El Pollo Loco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary El Pollo Loco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Imaging Dynamics Company Ltd (IDL)-医療機器分野:企業M&A・提携分析
    Summary Imaging Dynamics Company Ltd (IDC) is a medical technology company that offers solutions in medical imaging and digital radiography technology. The company provides flat panel technology, CCD technology, 2200 X-series, 1600 Plus X-series, 1600 X-series, 1590 X-series, image processing softwa …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Mashreqbank psc:企業の戦略・SWOT・財務情報
    Mashreqbank psc - Strategy, SWOT and Corporate Finance Report Summary Mashreqbank psc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Butterfield Private Banking:企業の戦略・SWOT・財務情報
    Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report Summary Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Compagnie Plastic Omnium SA (POM):企業の財務・戦略的SWOT分析
    Compagnie Plastic Omnium SA (POM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • VeriFone Systems Inc:企業の戦略・SWOT・財務情報
    VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report Summary VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Arab Bank (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DUAL International Ltd:企業の戦略・SWOT・財務情報
    DUAL International Ltd - Strategy, SWOT and Corporate Finance Report Summary DUAL International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析
    Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program i …
  • Bechtel Corp:企業の戦略的SWOT分析
    Bechtel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Circassia Pharmaceuticals Plc (CIR):製薬・医療:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • DTE Energy Company:企業の戦略・SWOT・財務情報
    DTE Energy Company - Strategy, SWOT and Corporate Finance Report Summary DTE Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Cyan Limited:企業の戦略・SWOT・財務情報
    Cyan Limited - Strategy, SWOT and Corporate Finance Report Summary Cyan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆